ARTP Award 2016 conferred to Domenico Albino

news on 20 Oct , 2016
At the 23th meeting of the European Association of Urology - Section of Urological Research (ESUR) held on October 20-22, 2016 in Parma Domenico Albino, PhD, from the IOR (Experimental Therapeutics and Prostate Cancer Biology) received the 2016 ARTP Award for the best paper in the field of urological research.
More

New study published in Oncotarget by Dr. Carbone group

news on 8 Oct , 2016
The study, conducted by Dr. Giuseppina Carbone and collaborators in Experimental Therapeutics and Prostate Cancer Biology, demonstrates that the transcription factor ESE3/EHF controls the IL-6/JAK/STAT3 axis and shows that targeting this pathway is beneficial in aggressive prostate tumors with reduced ESE3/EHF activity.
More

A New study published in The Journal of Clinical Investigation by Dr. Carbone group

news on 7 Nov , 2016
A new study has been published by the group led by Dr. Giuseppina Carbone at the Institute of Oncology Research (IOR). The article entitled “MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression” appears today in The Journal of Clinical Investigation. Mutations and deletions of components of ubiquitin ligase complexes leading to altered protein turnover ar...
More